SeaStar Medical Holding Corporation

NasdaqCM:ICU Stock Report

Market Cap: US$8.7m

SeaStar Medical Holding Management

Management criteria checks 3/4

SeaStar Medical Holding's CEO is Eric Schlorff, appointed in Jul 2019, has a tenure of 5.58 years. total yearly compensation is $637.96K, comprised of 65.8% salary and 34.2% bonuses, including company stock and options. directly owns 1.1% of the company’s shares, worth $95.81K. The average tenure of the management team and the board of directors is 2.6 years and 1.2 years respectively.

Key information

Eric Schlorff

Chief executive officer

US$638.0k

Total compensation

CEO salary percentage65.8%
CEO tenure5.6yrs
CEO ownership1.1%
Management average tenure2.6yrs
Board average tenure1.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Eric Schlorff's remuneration changed compared to SeaStar Medical Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$30m

Jun 30 2024n/an/a

-US$33m

Mar 31 2024n/an/a

-US$32m

Dec 31 2023US$638kUS$420k

-US$26m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$20m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$2mUS$320k

-US$12m

Sep 30 2022n/an/a

-US$5m

Jun 30 2022n/an/a

-US$4m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$323kUS$300k

-US$5m

Compensation vs Market: Eric's total compensation ($USD637.96K) is about average for companies of similar size in the US market ($USD638.68K).

Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.

CEO

Eric Schlorff (51 yo)

5.6yrs

Tenure

US$637,960

Compensation

Mr. Eric Schlorff serves as Chief Executive Officer and Executive Director of SeaStar Medical Holding Corporation since July 2019 and serves as its President. He served as Chief Operating Officer at LMF Ac...

Leadership Team

NamePositionTenureCompensationOwnership
Eric Schlorff
CEO, President & Executive Director5.6yrsUS$637.96k1.1%
$ 95.8k
Kevin Chung
Chief Medical Officer2.6yrsUS$495.31k0.31%
$ 26.8k
H. Humes
Co-Founder and Managing Director30.1yrsUS$205.93kno data
David Green
Chief Financial Officer1.1yrsno data0.23%
$ 20.2k
Tom Mullen
Vice President of Operations & Product Development3.1yrsno datano data
Tim Varacek
Senior VP of Commercial & Business Operationsless than a yearno datano data
Sai Iyer
Senior Vice President of Medical Affairs & Researchless than a yearno datano data

2.6yrs

Average Tenure

51yo

Average Age

Experienced Management: ICU's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Eric Schlorff
CEO, President & Executive Director5.6yrsUS$637.96k1.1%
$ 95.8k
Glenn Chertow
Member of Medical Advisory Boardno datano datano data
Ravindra Mehta
Member of Medical Advisory Boardno datano datano data
Kenneth Van Heel
Independent Director4.1yrsUS$88.16k0.054%
$ 4.7k
Richard Barnett
Independent Chairman4.1yrsUS$126.16k0.078%
$ 6.8k
Allan Collins
Independent Director4.1yrsUS$80.16k0.049%
$ 4.3k
David Askenazi
Member of Scientific Advisory Board1.2yrsno datano data
Ayse Akcan-Arikan
Member of Scientific Advisory Board1.2yrsno datano data
Sean Bagshaw
Member of Scientific Advisory Board1.2yrsno datano data
Rajit Basu
Member of Scientific Advisory Board1.2yrsno datano data
Andriy Batchinsky
Member of Scientific Advisory Board1.2yrsno datano data
John Neuman
Directorless than a yearno datano data

1.2yrs

Average Tenure

60yo

Average Age

Experienced Board: ICU's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/10 16:08
End of Day Share Price 2025/02/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SeaStar Medical Holding Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anthony VendettiMaxim Group